| Dr Hamid Qaiser Sial, MD | |
|
520 E Tulare Ave, Visalia, CA 93292-3629 | |
| (669) 327-8700 | |
| Not Available |
| Full Name | Dr Hamid Qaiser Sial |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 520 E Tulare Ave, Visalia, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003911637 | NPI | - | NPPES |
| 2087119101 | Medicaid | KS | |
| 8282170 | Medicaid | WA |
| Entity Name | County Of Napa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164572426 PECOS PAC ID: 7012991862 Enrollment ID: O20040617000918 |
News Archive
Today's news coverage includes more details about the Obama administration's new rule on appealing rejections of health insurance claims and a new law to reign in improper government payments.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Patients with septic shock admitted to hospitals affected by the 2011 shortage of the drug norepinephrine had a higher risk of in-hospital death, according to a study published online by JAMA.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson's disease, could also help thousands of stroke patients regain mobility and independence.
› Verified 7 days ago
| Entity Name | Department Of State Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124078704 PECOS PAC ID: 9638174238 Enrollment ID: O20081031000305 |
News Archive
Today's news coverage includes more details about the Obama administration's new rule on appealing rejections of health insurance claims and a new law to reign in improper government payments.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Patients with septic shock admitted to hospitals affected by the 2011 shortage of the drug norepinephrine had a higher risk of in-hospital death, according to a study published online by JAMA.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson's disease, could also help thousands of stroke patients regain mobility and independence.
› Verified 7 days ago
| Entity Name | Hiawatha Harris Md Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942420724 PECOS PAC ID: 1052580115 Enrollment ID: O20110805000150 |
News Archive
Today's news coverage includes more details about the Obama administration's new rule on appealing rejections of health insurance claims and a new law to reign in improper government payments.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Patients with septic shock admitted to hospitals affected by the 2011 shortage of the drug norepinephrine had a higher risk of in-hospital death, according to a study published online by JAMA.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson's disease, could also help thousands of stroke patients regain mobility and independence.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hamid Qaiser Sial, MD 520 E Tulare Ave, Visalia, CA 93292-3629 Ph: (669) 327-8700 | Dr Hamid Qaiser Sial, MD 520 E Tulare Ave, Visalia, CA 93292-3629 Ph: (669) 327-8700 |
News Archive
Today's news coverage includes more details about the Obama administration's new rule on appealing rejections of health insurance claims and a new law to reign in improper government payments.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
Patients with septic shock admitted to hospitals affected by the 2011 shortage of the drug norepinephrine had a higher risk of in-hospital death, according to a study published online by JAMA.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson's disease, could also help thousands of stroke patients regain mobility and independence.
› Verified 7 days ago
Dr. Joyce C Brown, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1216 N Pride Ct, Visalia, CA 93291 Phone: 559-622-0873 | |
Juan Roberto Sosa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Akers St, Visalia, CA 93277 Phone: 559-624-2000 | |
Dr. Reza John Emami, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Gagandeep Randhawa, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Akers St, Visalia, CA 93277 Phone: 559-624-3300 | |
Ravi M Mehta, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Vaic- Visalia Adult Integrative Clinic, 520 E Tulare Ave, Visalia, CA 93292 Phone: 559-602-2021 | |
Cory Daniel Jaques, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Akers St, Visalia, CA 93277 Phone: 559-624-3300 |